ES8302778A1 - Un procedimiento para producir un polipeptido antiviral. - Google Patents

Un procedimiento para producir un polipeptido antiviral.

Info

Publication number
ES8302778A1
ES8302778A1 ES506955A ES506955A ES8302778A1 ES 8302778 A1 ES8302778 A1 ES 8302778A1 ES 506955 A ES506955 A ES 506955A ES 506955 A ES506955 A ES 506955A ES 8302778 A1 ES8302778 A1 ES 8302778A1
Authority
ES
Spain
Prior art keywords
polypeptide
procedure
microorganism
producing
viral polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506955A
Other languages
English (en)
Other versions
ES506955A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES506955A0 publication Critical patent/ES506955A0/es
Publication of ES8302778A1 publication Critical patent/ES8302778A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN PROCEDIMIENTO PARA PRODUCIR UN POLIPEPTIDO ANTIVIRAL DE APROXIMADAMENTE 165 A 166 AMINOACIDOS. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE DESPLIEGA UN FRAGMENTO DE DNA, QUE COMPRENDE UN FILAMENTE QUE CODIFICA EL POLIPEPTIDO DENTRO DE UN VEHICULO DE EXPRESION PLASMIDICO; SEGUNDA, SE CULTIVA UN MICROORGANISMO QUE OCASIONA LA EXPRESION DEL SEGUNDO POLIPEPTIDO CODIFICADO; TERCERA, SE LISA EL MICROORGANISMO RESULTANTE; Y POR ULTIMO, SE RECUPERA DE DICHO MICROORGANISMO EL POLIPEPTIDO. DE APLICACION EN EL TRATAMIENTO DE ENFERMEDADES NEOPLASTICAS VIRALES.
ES506955A 1980-11-10 1981-11-07 Un procedimiento para producir un polipeptido antiviral. Expired ES8302778A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (2)

Publication Number Publication Date
ES506955A0 ES506955A0 (es) 1983-02-01
ES8302778A1 true ES8302778A1 (es) 1983-02-01

Family

ID=27394813

Family Applications (2)

Application Number Title Priority Date Filing Date
ES506955A Expired ES8302778A1 (es) 1980-11-10 1981-11-07 Un procedimiento para producir un polipeptido antiviral.
ES512354A Granted ES512354A0 (es) 1980-11-10 1982-05-19 "un procedimiento para formar dna doble filamentado".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES512354A Granted ES512354A0 (es) 1980-11-10 1982-05-19 "un procedimiento para formar dna doble filamentado".

Country Status (34)

Country Link
EP (1) EP0051873B1 (es)
JP (1) JP2642291B2 (es)
KR (1) KR920007439B1 (es)
AT (1) ATE46718T1 (es)
AU (1) AU555293B2 (es)
BR (1) BR8107293A (es)
CA (2) CA1212915A (es)
CH (2) CH660743A5 (es)
DE (2) DE3177106D1 (es)
DK (1) DK173590B1 (es)
DO (1) DOP1981004064A (es)
DZ (1) DZ350A1 (es)
ES (2) ES8302778A1 (es)
FI (1) FI79550C (es)
FR (1) FR2493867B1 (es)
GB (1) GB2090258B (es)
GR (1) GR81947B (es)
HK (1) HK51685A (es)
IE (1) IE51850B1 (es)
IL (1) IL64243A (es)
IT (1) IT1169276B (es)
KE (1) KE3536A (es)
LU (1) LU83745A1 (es)
MC (1) MC1424A1 (es)
MY (2) MY8700710A (es)
NL (1) NL189092C (es)
NO (1) NO165201C (es)
NZ (1) NZ198906A (es)
PH (1) PH18565A (es)
PL (1) PL233748A1 (es)
PT (1) PT73955B (es)
SE (1) SE460539B (es)
YU (1) YU46597B (es)
ZW (1) ZW26981A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60500574A (ja) * 1983-02-24 1985-04-25 インステイチユト　オルガニチエスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスア−ル ヒト白血球インタ−フェロンｎ及び細菌細胞におけるその製造方法
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst Pulmonary surfactant proteins.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
CA2223088A1 (en) 1995-06-07 1996-12-19 Bob Dale Brown Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
WO2004022593A2 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
WO2005113592A2 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2607651A1 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides

Also Published As

Publication number Publication date
NL8105078A (nl) 1982-06-01
PL233748A1 (en) 1983-07-18
ATE46718T1 (de) 1989-10-15
SE8106641L (sv) 1982-06-24
FI79550B (fi) 1989-09-29
ES506955A0 (es) 1983-02-01
ZW26981A1 (en) 1982-06-02
EP0051873A3 (en) 1982-09-22
NO165201C (no) 1991-01-16
KE3536A (en) 1985-06-07
NL189092C (nl) 1993-01-04
GB2090258A (en) 1982-07-07
PH18565A (en) 1985-08-09
IL64243A (en) 1985-11-29
PT73955A (en) 1981-12-01
DOP1981004064A (es) 1988-03-16
JPH07308191A (ja) 1995-11-28
ES8304200A1 (es) 1983-03-01
NO813785L (no) 1982-05-11
DZ350A1 (fr) 2004-09-13
NZ198906A (en) 1985-12-13
AU555293B2 (en) 1986-09-18
KR920007439B1 (ko) 1992-09-01
DE3177106D1 (en) 1989-11-02
FI813539L (fi) 1982-05-11
EP0051873B1 (en) 1989-09-27
LU83745A1 (de) 1983-09-01
NO165201B (no) 1990-10-01
KR830007825A (ko) 1983-11-07
MY8700710A (en) 1987-12-31
YU265681A (en) 1984-08-31
BR8107293A (pt) 1982-08-03
HK51685A (en) 1985-07-12
IE51850B1 (en) 1987-04-15
AU7730481A (en) 1982-05-20
FI79550C (fi) 1990-01-10
CA1277616C (en) 1990-12-11
IE812622L (en) 1982-05-10
FR2493867B1 (fr) 1986-06-27
GR81947B (es) 1984-12-12
IL64243A0 (en) 1982-02-28
GB2090258B (en) 1984-05-02
JP2642291B2 (ja) 1997-08-20
DE3144469A1 (de) 1982-09-02
CH660743A5 (de) 1987-06-15
EP0051873A2 (en) 1982-05-19
DK173590B1 (da) 2001-04-02
MC1424A1 (fr) 1982-10-18
CA1212915A (en) 1986-10-21
NL189092B (nl) 1992-08-03
YU46597B (sh) 1994-01-20
ES512354A0 (es) 1983-03-01
FR2493867A1 (fr) 1982-05-14
CH663032A5 (de) 1987-11-13
PT73955B (en) 1983-11-23
SE460539B (sv) 1989-10-23
IT1169276B (it) 1987-05-27
IT8124967A0 (it) 1981-11-10
DK494681A (da) 1982-05-11
MY8800066A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
ES8105386A1 (es) Metodo para construir un vehiculo de reproduccion o clona- cion
ES2108681T3 (es) Expresion de la albumina del suero humano en las levaduras metilotroficas.
BR8107293A (pt) Polipetidio anti-viral dna de duplo cordao veiculo de expressao plasmidico replicavel microorganismo transformado plasmidio processo de formacao do dito dna e do dito polipeptidio composicao farmaceutica e uso do dito polipeptidio
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
ES8207514A1 (es) Un procedimiento para la preparacion de interferon
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
ES2060158T3 (es) Uso de alcoholes alifaticos c-22 a c-26 en el tratamiento de enfermedades de la piel inflamatorias y viricas.
DE3785864D1 (de) Verfahren zur herstellung von menschlichem epidermalwachstumsfaktor und dessen analogen.
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2054353T3 (es) Expresion de las alipoproteinas humanas ai-milano en levadura.
ES8104412A1 (es) Procedimiento para la preparacion de un hidrolizado de pro- teinas purificado.
ES8705521A1 (es) Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
ES8401133A1 (es) Metodo para preparar albumina de suero humano o una proteina de fusion de la misma.
ATE192653T1 (de) Anwendungen von acemannan
ES8600783A1 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
ES8305828A1 (es) Un procedimiento para la preparacion de una proteina de fusion.
ES2010538A6 (es) Procedimiento para la preparacion de un gen sintetico.
SV1996000006A (es) Purin-6-onas bisustituidas en 2,9
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
ES2006476A6 (es) Un procedimiento para obtener interleukin-2 humana
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ES2043610T3 (es) Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.
ES2087092T3 (es) Procedimiento para la expresion de poligalacturonidasa y pectinesterasa en aspergillus niger y aspergillus awamori.
ES8707554A1 (es) Procedimiento para preparar interferon-a recombinante